UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

PV-0279: Role of IFRT prior or after autologous stem cell rescue for refractory or relapsed Hodgkin lymphoma

Radiotherapy and oncology, 2016-04, Vol.119, p.S130-S131

2016

Volltextzugriff (PDF)

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.147-148

2019

Volltextzugriff (PDF)

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.485-491

2014

Volltextzugriff (PDF)

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (6), p.509-511

2009

Volltextzugriff (PDF)

PO-0641 MEDIASTINAL B-CELL LYMPHOMA IN PET-RITUXIMAB ERA: PROGNOSTIC IMPACT OF INITIAL RESPONSE AND RADIATION THERAPY

Radiotherapy and oncology, 2012-05, Vol.103, p.S251-S251

2012

Volltextzugriff (PDF)

Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia

Leukemia research, 2008-03, Vol.32 (3), p.506-507

2008

Volltextzugriff (PDF)

CD7 CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536

Leukemia, 2007-06, Vol.21 (6), p.1305-1306

2007

Volltextzugriff (PDF)

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

Annals of oncology, 1998-01, Vol.9 (1), p.55-61

1998

Volltextzugriff (PDF)

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)

Blood, 2003-07, Vol.102 (2), p.749-755

2003

Volltextzugriff (PDF)

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma

Leukemia, 2002-02, Vol.16 (2), p.268-275

2002

Volltextzugriff (PDF)

PS1502 VALIDATION OF HAND GRIP STRENGTH AS A SCREENING TOOL FOR FRAILTY IN OLDER PATIENTS ON TREATMENT FOR HEMATOLOGIC MALIGNANCIES: THE FRAILTY TASK FORCE STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.692-n/a

2019

Volltextzugriff (PDF)

Follow-up of mediastinal lymphoma: role of ultrasonography

Radiologia medica, 2006-09, Vol.111 (6), p.759-772

2006

Volltextzugriff (PDF)

Analysis of microsatellite instability in chronic lymphoproliferative disorders

Annals of hematology, 1996-02, Vol.72 (2), p.67-71

1996

Volltextzugriff (PDF)

p53 Gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24

Leukemia, 1995-06, Vol.9 (6), p.955-959

1995

Volltextzugriff (PDF)

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial

Haematologica (Roma), 2005-06, Vol.90 (6), p.793-801

2005

Volltextzugriff (PDF)

Cd7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-κb subunit p65 at ser536

Leukemia, 2007, Vol.21 (6), p.1305-1306

2007

Volltextzugriff (PDF)

Bone Marrow Microenvironment and the Progression of Multiple Myeloma

Leukemia & lymphoma, 1992, Vol.8 (1-2), p.15-22

1992

Volltextzugriff (PDF)

BCL-2 in B-chronic lymphocytic leukemia

Current topics in microbiology and immunology, 1992, Vol.182, p.279

1992

Volltextzugriff (PDF)

Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications

Human pathology, 2000-07, Vol.31 (7), p.871-873

2000

Volltextzugriff (PDF)

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma

Leukemia, 2002-02, Vol.16 (2), p.268-275

2002

Volltextzugriff (PDF)

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders

Genes chromosomes & cancer, 1995-10, Vol.14 (2), p.106-111

1995

Volltextzugriff (PDF)

Molecular events in chronic myeloid leukemia progression

Leukemia, 1997-04, Vol.11, p.519-521

1997

Volltextzugriff (PDF)

Distribution of TP53 mutations among acute leukemias with MLL rearrangements

Genes chromosomes & cancer, 1996-01, Vol.15 (1), p.48-53

1996

Volltextzugriff (PDF)

Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia

Leukemia research, 2008, Vol.32 (3), p.506-507

2008

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Humans
(39)
Life Sciences & Biomedicine
(32)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Middle Aged
(20)
Male
(19)
Adult
(18)
Female
(17)
Oncology
(13)
Aged
(11)
Hematologic And Hematopoietic Diseases
(11)
Hematology
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(11)
Technology
(11)
Physics
(9)
Adolescent
(8)
Detectors And Experimental Techniques
(8)
Instruments & Instrumentation
(8)
Det
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PV-0279: Role of IFRT prior or after autologous stem cell rescue for refractory or relapsed Hodgkin lymphoma

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

PO-0641 MEDIASTINAL B-CELL LYMPHOMA IN PET-RITUXIMAB ERA: PROGNOSTIC IMPACT OF INITIAL RESPONSE AND RADIATION THERAPY

Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia

CD7 CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma

PS1502 VALIDATION OF HAND GRIP STRENGTH AS A SCREENING TOOL FOR FRAILTY IN OLDER PATIENTS ON TREATMENT FOR HEMATOLOGIC MALIGNANCIES: THE FRAILTY TASK FORCE STUDY

Follow-up of mediastinal lymphoma: role of ultrasonography

Analysis of microsatellite instability in chronic lymphoproliferative disorders

p53 Gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial

Cd7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-κb subunit p65 at ser536

Bone Marrow Microenvironment and the Progression of Multiple Myeloma

BCL-2 in B-chronic lymphocytic leukemia

Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: Pathogenetic and histogenetic implications

Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders

Molecular events in chronic myeloid leukemia progression

Distribution of TP53 mutations among acute leukemias with MLL rearrangements

Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia

Suchergebnisse filtern